These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31616641)

  • 21. Emerging patents in the therapeutic areas of glioma and glioblastoma.
    Harris M; Svensson F; Kopanitsa L; Ladds G; Bailey D
    Expert Opin Ther Pat; 2018 Jul; 28(7):573-590. PubMed ID: 29950117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel delivery methods bypassing the blood-brain and blood-tumor barriers.
    Hendricks BK; Cohen-Gadol AA; Miller JC
    Neurosurg Focus; 2015 Mar; 38(3):E10. PubMed ID: 25727219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
    Sarkaria JN; Hu LS; Parney IF; Pafundi DH; Brinkmann DH; Laack NN; Giannini C; Burns TC; Kizilbash SH; Laramy JK; Swanson KR; Kaufmann TJ; Brown PD; Agar NYR; Galanis E; Buckner JC; Elmquist WF
    Neuro Oncol; 2018 Jan; 20(2):184-191. PubMed ID: 29016900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
    ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.
    Dréan A; Goldwirt L; Verreault M; Canney M; Schmitt C; Guehennec J; Delattre JY; Carpentier A; Idbaih A
    Expert Rev Neurother; 2016 Nov; 16(11):1285-1300. PubMed ID: 27310463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Potential of Curcumin in the Treatment of Glioblastoma Multiforme.
    Shahcheraghi SH; Zangui M; Lotfi M; Ghayour-Mobarhan M; Ghorbani A; Jaliani HZ; Sadeghnia HR; Sahebkar A
    Curr Pharm Des; 2019; 25(3):333-342. PubMed ID: 30864499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma biomarkers from bench to bedside: advances and challenges.
    Farias-Eisner G; Bank AM; Hwang BY; Appelboom G; Piazza MA; Bruce SS; Sander Connolly E
    Br J Neurosurg; 2012 Apr; 26(2):189-94. PubMed ID: 22176646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.
    Halatsch ME; Schmidt U; Behnke-Mursch J; Unterberg A; Wirtz CR
    Cancer Treat Rev; 2006 Apr; 32(2):74-89. PubMed ID: 16488082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy in glioblastoma multiforme: Can it be a role changer?
    Rayati M; Mansouri V; Ahmadbeigi N
    Heliyon; 2024 Mar; 10(5):e27087. PubMed ID: 38439834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme.
    Chin C; Lunking ES; de la Fuente M; Ayad NG
    Front Oncol; 2018; 8():521. PubMed ID: 30483476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models.
    Kovacs Z; Werner B; Rassi A; Sass JO; Martin-Fiori E; Bernasconi M
    J Control Release; 2014 Aug; 187():74-82. PubMed ID: 24878186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New therapeutic strategies regarding endovascular treatment of glioblastoma, the role of the blood-brain barrier and new ways to bypass it.
    Peschillo S; Caporlingua A; Diana F; Caporlingua F; Delfini R
    J Neurointerv Surg; 2016 Oct; 8(10):1078-82. PubMed ID: 26541791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.
    Harder BG; Blomquist MR; Wang J; Kim AJ; Woodworth GF; Winkles JA; Loftus JC; Tran NL
    Front Oncol; 2018; 8():462. PubMed ID: 30406029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Monoclonal Antibodies Delivery for the Glioblastoma Treatment.
    Sousa F; Moura RP; Moreira E; Martins C; Sarmento B
    Adv Protein Chem Struct Biol; 2018; 112():61-80. PubMed ID: 29680243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging immunotherapies for glioblastoma.
    Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme.
    Lim XY; Capinpin SM; Bolem N; Foo ASC; Yip WG; Kumar AP; Teh DBL
    Bioeng Transl Med; 2023 May; 8(3):e10483. PubMed ID: 37206213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme.
    Ung N; Yang I
    J Neurooncol; 2015 Jul; 123(3):473-81. PubMed ID: 26070553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New therapeutic options in therapy of glioblastoma multiforme].
    Lakomý R; Burkon P; Burkonová D; Jancálek R
    Klin Onkol; 2010; 23(6):381-7. PubMed ID: 21351415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide vaccines for the treatment of glioblastoma.
    Swartz AM; Batich KA; Fecci PE; Sampson JH
    J Neurooncol; 2015 Jul; 123(3):433-40. PubMed ID: 25491947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.